Avanos Medical (AVNS) Cash from Operations (2013 - 2026)

Avanos Medical has disclosed Cash from Operations across 14 years of filings, most recently posting -$12.3 million for Q1 2026.

• In Q1 2026, Cash from Operations fell 147.86% year-over-year to -$12.3 million; the TTM figure through Mar 2026 stood at $36.7 million (down 72.69% YoY), while the FY2025 annual figure was $74.7 million, down 25.82% from the prior year.
• Cash from Operations came in at -$12.3 million for Q1 2026 at Avanos Medical, down from $28.2 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $57.9 million in Q4 2024 to a low of -$12.3 million in Q1 2026.
• Average Cash from Operations over 5 years is $16.8 million, with a median of $23.0 million recorded in 2024.
• Year-over-year, Cash from Operations tumbled 477.78% in 2023 and soared 1169.23% in 2024.
• Over 5 years, Cash from Operations stood at $33.7 million in 2022, then tumbled by 62.31% to $12.7 million in 2023, then surged by 355.91% to $57.9 million in 2024, then slumped by 51.3% to $28.2 million in 2025, then plunged by 143.62% to -$12.3 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$12.3 million in Q1 2026, $28.2 million in Q4 2025, and $14.0 million in Q3 2025.